文献速递心脏核医学肿瘤 PET/CT

心脏结节病患者静息杏仁核活性与心血管事件的关系

Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-14

该研究回顾性纳入40例接受FDG-PET的心脏结节病患者,随访4.5(2.5-7.7)年,14例(35%)发生心血管事件。左侧杏仁核活性升高是心血管事件的唯一独立预测因子(每升高0.1,HR 1.76,95%CI 1.12-2.87,P=0.016);首次PET与多次PET平均杏仁核活性无显著差异,相关系数0.93(P<0.001)。

要点

  • 左侧杏仁核活性高于右侧,高左侧杏仁核活性组心血管事件发生率显著高于低组(log-rank P=0.018)。
  • 左侧杏仁核活性每升高0.1,心血管事件风险HR 1.76(95%CI 1.12-2.87,P=0.016),为唯一独立预测因子。
  • 首次PET与多次PET平均杏仁核活性无显著差异,相关系数0.93(P<0.001),提示测量不受PET扫描时机影响。

核心结论

  • 高左侧杏仁核活性与心脏结节病患者更高的心血管事件发生率相关。
  • 杏仁核活性可能是不受PET扫描时机影响的预后生物标志物。

研究设计与样本

  • 回顾性识别连续40例接受FDG-PET的心脏结节病患者。
  • 心血管事件包括室性快速性心律失常和心力衰竭住院。
  • 分析杏仁核活性与心血管事件的关联,并探讨FDG-PET时机对杏仁核活性测量的影响。

主要发现

  • 随访4.5(2.5-7.7)年期间,14例(35%)患者发生心血管事件。
  • 左侧杏仁核活性比右侧杏仁核活性是更强的心血管事件预测因子,高左侧杏仁核活性组心血管事件发生率显著高于低组(log-rank P=0.018)。
  • 多变量分析显示左侧杏仁核活性升高(每升高0.1,HR 1.76,95%CI 1.12-2.87,P=0.016)是心血管事件的唯一独立预测因子。
  • 40例患者中32例接受多次PET扫描,首次PET扫描的杏仁核活性值与多次PET扫描的平均值之间无显著差异,相关系数0.93(P<0.001)。
  • 多变量分析显示平均左侧杏仁核活性值是心血管事件的唯一独立预测因子(P=0.011)。

关键数值与推荐

  • 心血管事件包括室性快速性心律失常和心力衰竭住院。
  • 高左侧杏仁核活性组与低左侧杏仁核活性组心血管事件发生率比较:log-rank P=0.018。
  • 左侧杏仁核活性每升高0.1的HR为1.76(95%CI 1.12-2.87,P=0.016)。
  • 首次PET扫描杏仁核活性值与多次PET扫描平均值的相关系数为0.93(P<0.001)。
  • 平均左侧杏仁核活性值预测心血管事件的P=0.011。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Previous studies indicate amygdala activity (AmygA) measured by FDG-positron emission tomography (PET) predicts the risk of subsequent cardiovascular events. However, AmygA measurement use for predicting the prognosis of patients with cardiac sarcoidosis (CS) is unknown. We aimed to investigate the association between AmygA and cardiovascular events in patients with CS. METHODS: Consecutive 40 patients with CS who underwent FDG-PET were identified retrospectively. Cardiovascular events included ventricular tachyarrhythmias and heart failure hospitalizations. We examined the association between AmygA and cardiovascular events and investigated the timing of FDG-PET influence on AmygA measurements. RESULTS: During a follow-up of 4.5 (2.5-7.7) years, 14 (35%) patients experienced cardiovascular events. Left-AmygA was a stronger cardiovascular event predictor than the Right-AmygA, and incidences were significantly higher in the high left-AmygA group than low group (log-rank P = 0.018). Multivariable analysis revealed left-AmygA augmentation (hazard ratio [HR]: 1.76 per 0.1 increase, 95% confidence interval [CI]: 1.12-2.87, P = 0.016) was the only independent predictor of cardiovascular event. Among the 40 patients, 32 underwent multiple PET-scans. No significant difference was found between the AmygA value on the first PET-scan and the mean on multiple PET scans, and the correlation coefficient was 0.93 (P < 0.001). Multivariate analyses revealed the mean left-AmygA value was the only independent predictor of cardiovascular event (P = 0.011). CONCLUSIONS: High left-AmygA was associated with the higher rates of cardiovascular events in patients with CS. AmygA would be a prognostic biomarker regardless of the PET-scan timing.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Otsuki S, Hatakeyama M, Kimura AM, et al. Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2025. PMID: 40227435. doi:10.1007/s00259-025-07266-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。